Trialtide flattens the whole ClinicalTrials.gov registry into one row per study: status, phase, design, enrollment, start and completion dates, conditions with MeSH terms, interventions, sponsor type, countries and site counts. Stopped trials carry a reason category. One Parquet file you can open in pandas or DuckDB, instead of paging through the API or paying per study.

Who this is for

Pharma and biotech analysts, CRO and site-selection teams, health-data scientists, and AI agents answering trial questions.

What the output looks like

Industry phase 3 trials recruiting now, most sites first (build of 24 Sep 2026, registry data 23 Sep)

NCT ID Lead sponsor Condition Enrolling Sites Primary completion

NCT07000357 AstraZeneca Cardiovascular disease 15,100 1,452 2029-10-26

NCT07181109 Alnylam Pharmaceuticals Hypertension 11,000 1,153 2030-09-23

NCT07064473 Boehringer Ingelheim Type 2 diabetes 11,800 1,143 2029-12-14

NCT06677060 AstraZeneca Heart failure 11,300 957 2029-12-17

NCT07567001 Novo Nordisk A/S…